Biblio
.
Cell fate decisions of human iPSC-derived bipotential hepatoblasts depend on cell density. PLoS One. 2018;13(7):e0200416.
. Establishment and characterization of an iPSC line from a 35 years old high grade patient with nonalcoholic fatty liver disease (30-40% steatosis) with homozygous wildtype PNPLA3 genotype. Stem Cell Res. 2018;31:113-116.
. Establishment and characterization of an iPSC line from a 58 years old high grade patient with nonalcoholic fatty liver disease (70% steatosis) with homozygous wildtype PNPLA3 genotype. Stem Cell Res. 2018;31:131-134.
. Fibroblast-derived integration-free iPSC line ISRM-NBS1 from an 18-year-old Nijmegen Breakage Syndrome patient carrying the homozygous NBN c.657_661del5 mutation. Stem Cell Res. 2018;34:101372.
. . Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A). Stem Cell Res. 2021;51:102167.
. In vitro differentiation of pluripotent stem cells into hepatocyte like cells - Basic principles and current progress. Stem Cell Res. 2022;61:102763.
. Forskolin induces FXR expression and enhances maturation of iPSC-derived hepatocyte-like cells. Front Cell Dev Biol. 2024;12:1383928.
.